NDSN NORDSON CORP

Nasdaq nordson.com


$ 233.28 $ 1.34 (0.58 %)    

Friday, 17-Oct-2025 15:59:54 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 233.34
$ 231.53
$ 225.03 x 1
$ 239.00 x 1
$ 230.60 - $ 233.53
$ 163.83 - $ 262.94
317,934
na
13.11B
$ 1.06
$ 28.81
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-21-2025 07-31-2025 10-Q
2 05-29-2025 04-30-2025 10-Q
3 02-20-2025 01-31-2025 10-Q
4 12-18-2024 10-31-2024 10-K
5 08-22-2024 07-31-2024 10-Q
6 05-23-2024 04-30-2024 10-Q
7 02-22-2024 01-31-2024 10-Q
8 12-20-2023 10-31-2023 10-K
9 08-24-2023 07-31-2023 10-Q
10 05-25-2023 04-30-2023 10-Q
11 02-23-2023 01-31-2023 10-Q
12 12-19-2022 10-31-2022 10-K
13 08-26-2022 07-31-2022 10-Q
14 05-27-2022 04-30-2022 10-Q
15 02-25-2022 01-31-2022 10-Q
16 12-17-2021 10-31-2021 10-K
17 08-31-2021 07-31-2021 10-Q
18 05-28-2021 04-30-2021 10-Q
19 03-04-2021 01-31-2021 10-Q
20 12-18-2020 10-31-2020 10-K
21 09-04-2020 07-31-2020 10-Q
22 06-05-2020 04-30-2020 10-Q
23 03-05-2020 01-31-2020 10-Q
24 12-13-2019 10-31-2019 10-K
25 09-05-2019 07-31-2019 10-Q
26 06-06-2019 04-30-2019 10-Q
27 03-07-2019 01-31-2019 10-Q
28 12-14-2018 10-31-2018 10-K
29 09-04-2018 07-31-2018 10-Q
30 06-04-2018 04-30-2018 10-Q
31 03-05-2018 01-31-2018 10-Q
32 12-15-2017 10-31-2017 10-K
33 09-05-2017 07-31-2017 10-Q
34 06-09-2017 04-30-2017 10-Q
35 03-06-2017 01-31-2017 10-Q
36 12-15-2016 10-31-2016 10-K
37 09-06-2016 07-31-2016 10-Q
38 06-08-2016 04-30-2016 10-Q
39 03-07-2016 01-31-2016 10-Q
40 12-15-2015 10-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 nordson-medical-completes-divestiture-of-select-contract-manufacturing-products-narrowing-its-focus-on-proprietary-medical-components

Nordson Corporation (NASDAQ:NDSN) has completed the divestiture of select product lines within its medical contract manufacturi...

 oppenheimer-maintains-outperform-on-nordson-raises-price-target-to-275

Oppenheimer analyst Christopher Glynn maintains Nordson (NASDAQ:NDSN) with a Outperform and raises the price target from $26...

 baird-maintains-neutral-on-nordson-raises-price-target-to-252

Baird analyst Michael Halloran maintains Nordson (NASDAQ:NDSN) with a Neutral and raises the price target from $245 to $252.

 tech-stocks-eye-third-day-of-losses-walmart-sinks-whats-moving-markets-thursday

Technology stocks on the Nasdaq 100 were poised for a third consecutive day of losses Thursday, as investors continued to adopt...

 stock-market-today-dow-sp-500-futures-tumble-as-jobless-claims-increase-walmart-intuit-ross-stores-earnings-in-focus-updated

U.S. stock futures were slightly below the flatline on Thursday following Wednesday's mixed close. Futures were lower.

 walmart-nordson-and-3-stocks-to-watch-heading-into-thursday

US stock futures mixed, may focus on Walmart, Coty, Intuit earnings. Nordson beats estimates, Ross Stores to report after close.

 nordson-stock-jumps-5-after-hours-as-q3-earnings-beat-analyst-estimates

Nordson Corp. surged over 5% after hours Wednesday following a Q3 earnings and revenue beat driven by double-digit growth in ke...

 nordson-beats-q3-earnings-estimates-shares-move-higher

Nordson reported third-quarter revenue of $741.51 million, beating analyst estimates of $722.57 million, according to Benzinga ...

 nordson-fy25-guidance-reaffirmed-sales-2750b2870b-eps-9701050-sales-tracking-slightly-below-midpoint-eps-above

Nordson (NASDAQ:NDSN) FY25 guidance reaffirmed: sales $2.750B–$2.870B, EPS $9.70–$10.50; sales tracking slightly below midpoint...

 on-august-18-nordson-corp-board-authorized-repurchase-of-additional-500m-of-outstanding-common-shares

-SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION